FR2710842B1 - Nouvelle application thérapeutique de dérivés de perhydroisoindole. - Google Patents

Nouvelle application thérapeutique de dérivés de perhydroisoindole.

Info

Publication number
FR2710842B1
FR2710842B1 FR9311945A FR9311945A FR2710842B1 FR 2710842 B1 FR2710842 B1 FR 2710842B1 FR 9311945 A FR9311945 A FR 9311945A FR 9311945 A FR9311945 A FR 9311945A FR 2710842 B1 FR2710842 B1 FR 2710842B1
Authority
FR
France
Prior art keywords
new therapeutic
therapeutic application
perhydroisoindole derivatives
perhydroisoindole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9311945A
Other languages
English (en)
Other versions
FR2710842A1 (fr
Inventor
Erik Louvel
Claude Garret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9311945A priority Critical patent/FR2710842B1/fr
Priority to PCT/FR1994/001160 priority patent/WO1995009628A1/fr
Priority to AU78581/94A priority patent/AU7858194A/en
Publication of FR2710842A1 publication Critical patent/FR2710842A1/fr
Application granted granted Critical
Publication of FR2710842B1 publication Critical patent/FR2710842B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR9311945A 1993-10-07 1993-10-07 Nouvelle application thérapeutique de dérivés de perhydroisoindole. Expired - Fee Related FR2710842B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9311945A FR2710842B1 (fr) 1993-10-07 1993-10-07 Nouvelle application thérapeutique de dérivés de perhydroisoindole.
PCT/FR1994/001160 WO1995009628A1 (fr) 1993-10-07 1994-10-05 Application therapeutique de derives de perhydroisoindole comme antiemetique
AU78581/94A AU7858194A (en) 1993-10-07 1994-10-05 Therapeutic application of perhydroisoindole derivatives as an anti-emetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311945A FR2710842B1 (fr) 1993-10-07 1993-10-07 Nouvelle application thérapeutique de dérivés de perhydroisoindole.

Publications (2)

Publication Number Publication Date
FR2710842A1 FR2710842A1 (fr) 1995-04-14
FR2710842B1 true FR2710842B1 (fr) 1995-11-24

Family

ID=9451619

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9311945A Expired - Fee Related FR2710842B1 (fr) 1993-10-07 1993-10-07 Nouvelle application thérapeutique de dérivés de perhydroisoindole.

Country Status (3)

Country Link
AU (1) AU7858194A (fr)
FR (1) FR2710842B1 (fr)
WO (1) WO1995009628A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654725B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
EP1082959A1 (fr) * 1991-09-20 2001-03-14 Glaxo Group Limited Utilisation des NK1-antagonistes pour le traitement de la depression
FR2689888B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AU7858194A (en) 1995-05-01
FR2710842A1 (fr) 1995-04-14
WO1995009628A1 (fr) 1995-04-13

Similar Documents

Publication Publication Date Title
TR28718A (tr) Dinamik takilan tipte cocuk bezi.
FR2706456B1 (fr) Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FR2690919B1 (fr) Dérivés de l'indole.
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
NL350032I2 (nl) Pyrazool-4-yl-benzoylderivaten de toepassing ervanals herbiciden
DZ1998A1 (fr) Dérivés de n-(3-benzofuranyl)-urée.
DE59605843D1 (de) Photovernetzbare flüssigkristalline 1,2-Phenylen-Derivate
DK0876392T3 (da) Lacton-derivater af 17.beta.-carboxy, carbothio og amidandrostanforbindelser
PT754407E (pt) Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
FR2696740B1 (fr) Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
MX224819B (es) Empleo cosmetico de derivados de bis(resorcinil)triacina.
FR2693192B1 (fr) Dérivés de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FI934748A0 (fi) Foerfarande foer framstaellning av l-5-(2-acetoxipropionylamino)-2,4,6-trijod-isoftalsyradiklorid
MA24421A1 (fr) Nouvelle application therapeutique de derives du pyrrole.
FR2713641B1 (fr) Dérivés de l'épi-épibatidine.
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
DZ1965A1 (fr) Composition pharmaceutique nouvelle.
MX9204370A (es) Derivados de pirazol.
NO972410D0 (no) Hydrogenering av halogenerte forbindelser
NO982562D0 (no) Sammensetning for behandling av smerte
FR2710842B1 (fr) Nouvelle application thérapeutique de dérivés de perhydroisoindole.
DZ1985A1 (fr) Dérivés d'indole substitués.
FR2709959B1 (fr) Nouvelle forme galénique de phloroglucinol.

Legal Events

Date Code Title Description
ST Notification of lapse